All tumors, however, showed complete loss of nuclear SMARCB1/INI1 protein expression and were unequivocally classified as ATRT–SHH using the Heidelberg Brain Tumor Classifier [median calibrated classifier score: 1.00 (Classifier version 12.3)]. This evidence concerns the gene SHH and brain neoplasm.